APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Hereditary Disease Testing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Hereditary Disease Testing Market Analysis and Forecast 2026-2032

1 January 2026196 pages

Choose your research edition.

Industry ResearchHereditary Disease Testing Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Hereditary Disease Testing Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Hereditary Disease Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hereditary Disease Testing Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Hereditary Disease Testing Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Hereditary Disease Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Hereditary Disease Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Hereditary Disease Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Hereditary Disease Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Hereditary Disease Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Hereditary Disease Testing include Myriad Genetics, Invitae, Illumina, Natera, Laboratory Corporation of America Holdings, F. Hoffmann-La Roche, Quest Diagnostics, CooperSurgical and Agilent Technologies, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Hereditary Disease Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Hereditary Disease Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Hereditary Disease Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hereditary Disease Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Hereditary Disease Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Hereditary Disease Testing revenue, projected growth trends, production technology, application and end-user industry.

Hereditary Disease Testing Segment by Company

Myriad Genetics

Invitae

Illumina

Natera

Laboratory Corporation of America Holdings

F. Hoffmann-La Roche

Quest Diagnostics

CooperSurgical

Agilent Technologies

Thermo Fisher Scientific

Twist Bioscience

Sophia Genetics

Fulgent Genetic

Medgenome

CENTOGENE

Hereditary Disease Testing Segment by Type

Hereditary Cancer Testing

Hereditary Non-cancer Testing

Hereditary Disease Testing Segment by Application

Hospital

Clinic

Laboratory

Others

Hereditary Disease Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hereditary Disease Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hereditary Disease Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hereditary Disease Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Hereditary Disease Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Hereditary Disease Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hereditary Disease Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hereditary Disease Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Hereditary Cancer Testing Major Player Table 3. Hereditary Non-cancer Testing Major Player Table 4. Global Hereditary Disease Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Clinic Major Player Table 7. Laboratory Major Player Table 8. Others Major Player Table 9. Hereditary Disease Testing Industry Trends Table 10. Hereditary Disease Testing Industry Drivers Table 11. Hereditary Disease Testing Industry Opportunities and Challenges Table 12. Hereditary Disease Testing Industry Restraints Table 13. Global Hereditary Disease Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Hereditary Disease Testing Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Hereditary Disease Testing Market Share by Region (2021-2026) Table 16. Global Hereditary Disease Testing Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Hereditary Disease Testing Market Share by Region (2027-2032) Table 18. Global Hereditary Disease Testing Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Hereditary Disease Testing Revenue Market Share by Players (2021-2026) Table 20. Global Hereditary Disease Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Hereditary Disease Testing Key Players Headquarters & Area Served Table 22. Global Hereditary Disease Testing Players, Product Type & Application Table 23. Global Hereditary Disease Testing Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Hereditary Disease Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Hereditary Disease Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Hereditary Disease Testing Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Hereditary Disease Testing Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Hereditary Disease Testing Revenue Market Share by Type (2021-2026) Table 30. Global Hereditary Disease Testing Revenue Market Share by Type (2027-2032) Table 31. Global Hereditary Disease Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Hereditary Disease Testing Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Hereditary Disease Testing Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Hereditary Disease Testing Revenue Market Share by Application (2021-2026) Table 35. Global Hereditary Disease Testing Revenue Market Share by Application (2027-2032) Table 36. Myriad Genetics Company Information Table 37. Myriad Genetics Business Overview Table 38. Myriad Genetics Hereditary Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Myriad Genetics Hereditary Disease Testing Product Portfolio Table 40. Myriad Genetics Recent Development Table 41. Invitae Company Information Table 42. Invitae Business Overview Table 43. Invitae Hereditary Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Invitae Hereditary Disease Testing Product Portfolio Table 45. Invitae Recent Development Table 46. Illumina Company Information Table 47. Illumina Business Overview Table 48. Illumina Hereditary Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Illumina Hereditary Disease Testing Product Portfolio Table 50. Illumina Recent Development Table 51. Natera Company Information Table 52. Natera Business Overview Table 53. Natera Hereditary Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Natera Hereditary Disease Testing Product Portfolio Table 55. Natera Recent Development Table 56. Laboratory Corporation of America Holdings Company Information Table 57. Laboratory Corporation of America Holdings Business Overview Table 58. Laboratory Corporation of America Holdings Hereditary Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Laboratory Corporation of America Holdings Hereditary Disease Testing Product Portfolio Table 60. Laboratory Corporation of America Holdings Recent Development Table 61. F. Hoffmann-La Roche Company Information Table 62. F. Hoffmann-La Roche Business Overview Table 63. F. Hoffmann-La Roche Hereditary Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. F. Hoffmann-La Roche Hereditary Disease Testing Product Portfolio Table 65. F. Hoffmann-La Roche Recent Development Table 66. Quest Diagnostics Company Information Table 67. Quest Diagnostics Business Overview Table 68. Quest Diagnostics Hereditary Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Quest Diagnostics Hereditary Disease Testing Product Portfolio Table 70. Quest Diagnostics Recent Development Table 71. CooperSurgical Company Information Table 72. CooperSurgical Business Overview Table 73. CooperSurgical Hereditary Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. CooperSurgical Hereditary Disease Testing Product Portfolio Table 75. CooperSurgical Recent Development Table 76. Agilent Technologies Company Information Table 77. Agilent Technologies Business Overview Table 78. Agilent Technologies Hereditary Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Agilent Technologies Hereditary Disease Testing Product Portfolio Table 80. Agilent Technologies Recent Development Table 81. Thermo Fisher Scientific Company Information Table 82. Thermo Fisher Scientific Business Overview Table 83. Thermo Fisher Scientific Hereditary Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Thermo Fisher Scientific Hereditary Disease Testing Product Portfolio Table 85. Thermo Fisher Scientific Recent Development Table 86. Twist Bioscience Company Information Table 87. Twist Bioscience Business Overview Table 88. Twist Bioscience Hereditary Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Twist Bioscience Hereditary Disease Testing Product Portfolio Table 90. Twist Bioscience Recent Development Table 91. Sophia Genetics Company Information Table 92. Sophia Genetics Business Overview Table 93. Sophia Genetics Hereditary Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Sophia Genetics Hereditary Disease Testing Product Portfolio Table 95. Sophia Genetics Recent Development Table 96. Fulgent Genetic Company Information Table 97. Fulgent Genetic Business Overview Table 98. Fulgent Genetic Hereditary Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Fulgent Genetic Hereditary Disease Testing Product Portfolio Table 100. Fulgent Genetic Recent Development Table 101. Medgenome Company Information Table 102. Medgenome Business Overview Table 103. Medgenome Hereditary Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Medgenome Hereditary Disease Testing Product Portfolio Table 105. Medgenome Recent Development Table 106. CENTOGENE Company Information Table 107. CENTOGENE Business Overview Table 108. CENTOGENE Hereditary Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. CENTOGENE Hereditary Disease Testing Product Portfolio Table 110. CENTOGENE Recent Development Table 111. North America Hereditary Disease Testing Revenue by Type (2021-2026) & (US$ Million) Table 112. North America Hereditary Disease Testing Revenue by Type (2027-2032) & (US$ Million) Table 113. North America Hereditary Disease Testing Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Hereditary Disease Testing Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Hereditary Disease Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Hereditary Disease Testing Revenue by Country (2021-2026) & (US$ Million) Table 117. North America Hereditary Disease Testing Revenue by Country (US$ Million) & (2027-2032) Table 118. Europe Hereditary Disease Testing Revenue by Type (2021-2026) & (US$ Million) Table 119. Europe Hereditary Disease Testing Revenue by Type (2027-2032) & (US$ Million) Table 120. Europe Hereditary Disease Testing Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe Hereditary Disease Testing Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe Hereditary Disease Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Hereditary Disease Testing Revenue by Country (2021-2026) & (US$ Million) Table 124. Europe Hereditary Disease Testing Revenue by Country (US$ Million) & (2027-2032) Table 125. China Hereditary Disease Testing Revenue by Type (2021-2026) & (US$ Million) Table 126. China Hereditary Disease Testing Revenue by Type (2027-2032) & (US$ Million) Table 127. China Hereditary Disease Testing Revenue by Application (2021-2026) & (US$ Million) Table 128. China Hereditary Disease Testing Revenue by Application (2027-2032) & (US$ Million) Table 129. Asia Hereditary Disease Testing Revenue by Type (2021-2026) & (US$ Million) Table 130. Asia Hereditary Disease Testing Revenue by Type (2027-2032) & (US$ Million) Table 131. Asia Hereditary Disease Testing Revenue by Application (2021-2026) & (US$ Million) Table 132. Asia Hereditary Disease Testing Revenue by Application (2027-2032) & (US$ Million) Table 133. Asia Hereditary Disease Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Asia Hereditary Disease Testing Revenue by Region (US$ Million) & (2021-2026) Table 135. Asia Hereditary Disease Testing Revenue by Region (US$ Million) & (2027-2032) Table 136. SAMEA Hereditary Disease Testing Revenue by Type (2021-2026) & (US$ Million) Table 137. SAMEA Hereditary Disease Testing Revenue by Type (2027-2032) & (US$ Million) Table 138. SAMEA Hereditary Disease Testing Revenue by Application (2021-2026) & (US$ Million) Table 139. SAMEA Hereditary Disease Testing Revenue by Application (2027-2032) & (US$ Million) Table 140. SAMEA Hereditary Disease Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. SAMEA Hereditary Disease Testing Revenue by Country (2021-2026) & (US$ Million) Table 142. SAMEA Hereditary Disease Testing Revenue by Country (US$ Million) & (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Hereditary Disease Testing Image Figure 2. Global Hereditary Disease Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hereditary Disease Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Hereditary Cancer Testing Image Figure 5. Hereditary Non-cancer Testing Image Figure 6. Global Hereditary Disease Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Hereditary Disease Testing Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Laboratory Image Figure 11. Others Image Figure 12. Global Hereditary Disease Testing Market Size (US$ Million) & (2021-2032) Figure 13. Global Hereditary Disease Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Hereditary Disease Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Hereditary Disease Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Hereditary Disease Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Hereditary Disease Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Hereditary Disease Testing Revenue Market Share by Type (2021-2032) Figure 20. Global Hereditary Disease Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Hereditary Disease Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Hereditary Disease Testing Revenue Market Share by Application (2021-2032) Figure 23. North America Hereditary Disease Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Hereditary Disease Testing Revenue Share by Type (2021-2032) Figure 25. North America Hereditary Disease Testing Revenue Share by Application (2021-2032) Figure 26. North America Hereditary Disease Testing Revenue Share by Country (2021-2032) Figure 27. United States Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Hereditary Disease Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Hereditary Disease Testing Revenue Share by Type (2021-2032) Figure 32. Europe Hereditary Disease Testing Revenue Share by Application (2021-2032) Figure 33. Europe Hereditary Disease Testing Revenue Share by Country (2021-2032) Figure 34. Germany Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Hereditary Disease Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Hereditary Disease Testing Revenue Share by Type (2021-2032) Figure 44. China Hereditary Disease Testing Revenue Share by Application (2021-2032) Figure 45. Asia Hereditary Disease Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Hereditary Disease Testing Revenue Share by Type (2021-2032) Figure 47. Asia Hereditary Disease Testing Revenue Share by Application (2021-2032) Figure 48. Asia Hereditary Disease Testing Revenue Share by Region (2021-2032) Figure 49. Japan Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Hereditary Disease Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Hereditary Disease Testing Revenue Share by Type (2021-2032) Figure 57. SAMEA Hereditary Disease Testing Revenue Share by Application (2021-2032) Figure 58. SAMEA Hereditary Disease Testing Revenue Share by Country (2021-2032) Figure 59. Brazil Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Hereditary Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Hereditary Cancer Testing
  • Hereditary Non-cancer Testing
Applications
  • Hospital
  • Clinic
  • Laboratory
  • Others
Companies covered
  • Myriad Genetics
  • Invitae
  • Illumina
  • Natera
  • Laboratory Corporation of America Holdings
  • F. Hoffmann-La Roche
  • Quest Diagnostics
  • CooperSurgical
  • Agilent Technologies
  • Thermo Fisher Scientific
  • Twist Bioscience
  • Sophia Genetics
  • Fulgent Genetic
  • Medgenome
  • CENTOGENE

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Hereditary Disease Testing Market by Type
  3. 1.2.1 Global Hereditary Disease Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Hereditary Cancer Testing
  5. 1.2.3 Hereditary Non-cancer Testing
  6. 1.3 Hereditary Disease Testing Market by Application
  7. 1.3.1 Global Hereditary Disease Testing Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Laboratory
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Hereditary Disease Testing Market Dynamics
  1. 2.1 Hereditary Disease Testing Industry Trends
  2. 2.2 Hereditary Disease Testing Industry Drivers
  3. 2.3 Hereditary Disease Testing Industry Opportunities and Challenges
  4. 2.4 Hereditary Disease Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Hereditary Disease Testing Market Perspective (2021-2032)
  2. 3.2 Global Hereditary Disease Testing Growth Trends by Region
  3. 3.2.1 Global Hereditary Disease Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Hereditary Disease Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global Hereditary Disease Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Hereditary Disease Testing Revenue by Players
  2. 4.1.1 Global Hereditary Disease Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global Hereditary Disease Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Hereditary Disease Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Hereditary Disease Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Hereditary Disease Testing Key Players Headquarters & Area Served
  7. 4.4 Global Hereditary Disease Testing Players, Product Type & Application
  8. 4.5 Global Hereditary Disease Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Hereditary Disease Testing Market CR5 and HHI
  11. 4.6.3 2025 Hereditary Disease Testing Tier 1, Tier 2, and Tier 3
5 Hereditary Disease Testing Market Size by Type
  1. 5.1 Global Hereditary Disease Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Hereditary Disease Testing Revenue by Type (2021-2032)
  3. 5.3 Global Hereditary Disease Testing Revenue Market Share by Type (2021-2032)
6 Hereditary Disease Testing Market Size by Application
  1. 6.1 Global Hereditary Disease Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Hereditary Disease Testing Revenue by Application (2021-2032)
  3. 6.3 Global Hereditary Disease Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Myriad Genetics
  2. 7.1.1 Myriad Genetics Company Information
  3. 7.1.2 Myriad Genetics Business Overview
  4. 7.1.3 Myriad Genetics Hereditary Disease Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Myriad Genetics Hereditary Disease Testing Product Portfolio
  6. 7.1.5 Myriad Genetics Recent Developments
  7. 7.2 Invitae
  8. 7.2.1 Invitae Company Information
  9. 7.2.2 Invitae Business Overview
  10. 7.2.3 Invitae Hereditary Disease Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Invitae Hereditary Disease Testing Product Portfolio
  12. 7.2.5 Invitae Recent Developments
  13. 7.3 Illumina
  14. 7.3.1 Illumina Company Information
  15. 7.3.2 Illumina Business Overview
  16. 7.3.3 Illumina Hereditary Disease Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Illumina Hereditary Disease Testing Product Portfolio
  18. 7.3.5 Illumina Recent Developments
  19. 7.4 Natera
  20. 7.4.1 Natera Company Information
  21. 7.4.2 Natera Business Overview
  22. 7.4.3 Natera Hereditary Disease Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Natera Hereditary Disease Testing Product Portfolio
  24. 7.4.5 Natera Recent Developments
  25. 7.5 Laboratory Corporation of America Holdings
  26. 7.5.1 Laboratory Corporation of America Holdings Company Information
  27. 7.5.2 Laboratory Corporation of America Holdings Business Overview
  28. 7.5.3 Laboratory Corporation of America Holdings Hereditary Disease Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Laboratory Corporation of America Holdings Hereditary Disease Testing Product Portfolio
  30. 7.5.5 Laboratory Corporation of America Holdings Recent Developments
  31. 7.6 F. Hoffmann-La Roche
  32. 7.6.1 F. Hoffmann-La Roche Company Information
  33. 7.6.2 F. Hoffmann-La Roche Business Overview
  34. 7.6.3 F. Hoffmann-La Roche Hereditary Disease Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 F. Hoffmann-La Roche Hereditary Disease Testing Product Portfolio
  36. 7.6.5 F. Hoffmann-La Roche Recent Developments
  37. 7.7 Quest Diagnostics
  38. 7.7.1 Quest Diagnostics Company Information
  39. 7.7.2 Quest Diagnostics Business Overview
  40. 7.7.3 Quest Diagnostics Hereditary Disease Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Quest Diagnostics Hereditary Disease Testing Product Portfolio
  42. 7.7.5 Quest Diagnostics Recent Developments
  43. 7.8 CooperSurgical
  44. 7.8.1 CooperSurgical Company Information
  45. 7.8.2 CooperSurgical Business Overview
  46. 7.8.3 CooperSurgical Hereditary Disease Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 CooperSurgical Hereditary Disease Testing Product Portfolio
  48. 7.8.5 CooperSurgical Recent Developments
  49. 7.9 Agilent Technologies
  50. 7.9.1 Agilent Technologies Company Information
  51. 7.9.2 Agilent Technologies Business Overview
  52. 7.9.3 Agilent Technologies Hereditary Disease Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Agilent Technologies Hereditary Disease Testing Product Portfolio
  54. 7.9.5 Agilent Technologies Recent Developments
  55. 7.10 Thermo Fisher Scientific
  56. 7.10.1 Thermo Fisher Scientific Company Information
  57. 7.10.2 Thermo Fisher Scientific Business Overview
  58. 7.10.3 Thermo Fisher Scientific Hereditary Disease Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Thermo Fisher Scientific Hereditary Disease Testing Product Portfolio
  60. 7.10.5 Thermo Fisher Scientific Recent Developments
  61. 7.11 Twist Bioscience
  62. 7.11.1 Twist Bioscience Company Information
  63. 7.11.2 Twist Bioscience Business Overview
  64. 7.11.3 Twist Bioscience Hereditary Disease Testing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Twist Bioscience Hereditary Disease Testing Product Portfolio
  66. 7.11.5 Twist Bioscience Recent Developments
  67. 7.12 Sophia Genetics
  68. 7.12.1 Sophia Genetics Company Information
  69. 7.12.2 Sophia Genetics Business Overview
  70. 7.12.3 Sophia Genetics Hereditary Disease Testing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Sophia Genetics Hereditary Disease Testing Product Portfolio
  72. 7.12.5 Sophia Genetics Recent Developments
  73. 7.13 Fulgent Genetic
  74. 7.13.1 Fulgent Genetic Company Information
  75. 7.13.2 Fulgent Genetic Business Overview
  76. 7.13.3 Fulgent Genetic Hereditary Disease Testing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Fulgent Genetic Hereditary Disease Testing Product Portfolio
  78. 7.13.5 Fulgent Genetic Recent Developments
  79. 7.14 Medgenome
  80. 7.14.1 Medgenome Company Information
  81. 7.14.2 Medgenome Business Overview
  82. 7.14.3 Medgenome Hereditary Disease Testing Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Medgenome Hereditary Disease Testing Product Portfolio
  84. 7.14.5 Medgenome Recent Developments
  85. 7.15 CENTOGENE
  86. 7.15.1 CENTOGENE Company Information
  87. 7.15.2 CENTOGENE Business Overview
  88. 7.15.3 CENTOGENE Hereditary Disease Testing Revenue and Gross Margin (2021-2026)
  89. 7.15.4 CENTOGENE Hereditary Disease Testing Product Portfolio
  90. 7.15.5 CENTOGENE Recent Developments
8 North America
  1. 8.1 North America Hereditary Disease Testing Revenue (2021-2032)
  2. 8.2 North America Hereditary Disease Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America Hereditary Disease Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America Hereditary Disease Testing Revenue by Type (2027-2032)
  5. 8.3 North America Hereditary Disease Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America Hereditary Disease Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America Hereditary Disease Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America Hereditary Disease Testing Revenue by Application (2027-2032)
  9. 8.5 North America Hereditary Disease Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America Hereditary Disease Testing Revenue by Country
  11. 8.6.1 North America Hereditary Disease Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Hereditary Disease Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America Hereditary Disease Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Hereditary Disease Testing Revenue (2021-2032)
  2. 9.2 Europe Hereditary Disease Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Hereditary Disease Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Hereditary Disease Testing Revenue by Type (2027-2032)
  5. 9.3 Europe Hereditary Disease Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Hereditary Disease Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Hereditary Disease Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Hereditary Disease Testing Revenue by Application (2027-2032)
  9. 9.5 Europe Hereditary Disease Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Hereditary Disease Testing Revenue by Country
  11. 9.6.1 Europe Hereditary Disease Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Hereditary Disease Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Hereditary Disease Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Hereditary Disease Testing Revenue (2021-2032)
  2. 10.2 China Hereditary Disease Testing Revenue by Type (2021-2032)
  3. 10.2.1 China Hereditary Disease Testing Revenue by Type (2021-2026)
  4. 10.2.2 China Hereditary Disease Testing Revenue by Type (2027-2032)
  5. 10.3 China Hereditary Disease Testing Revenue Share by Type (2021-2032)
  6. 10.4 China Hereditary Disease Testing Revenue by Application (2021-2032)
  7. 10.4.1 China Hereditary Disease Testing Revenue by Application (2021-2026)
  8. 10.4.2 China Hereditary Disease Testing Revenue by Application (2027-2032)
  9. 10.5 China Hereditary Disease Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Hereditary Disease Testing Revenue (2021-2032)
  2. 11.2 Asia Hereditary Disease Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Hereditary Disease Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Hereditary Disease Testing Revenue by Type (2027-2032)
  5. 11.3 Asia Hereditary Disease Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Hereditary Disease Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Hereditary Disease Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Hereditary Disease Testing Revenue by Application (2027-2032)
  9. 11.5 Asia Hereditary Disease Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Hereditary Disease Testing Revenue by Country
  11. 11.6.1 Asia Hereditary Disease Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Hereditary Disease Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Hereditary Disease Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Hereditary Disease Testing Revenue (2021-2032)
  2. 12.2 SAMEA Hereditary Disease Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Hereditary Disease Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Hereditary Disease Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Hereditary Disease Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Hereditary Disease Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Hereditary Disease Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Hereditary Disease Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Hereditary Disease Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Hereditary Disease Testing Revenue by Country
  11. 12.6.1 SAMEA Hereditary Disease Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Hereditary Disease Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Hereditary Disease Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst